MANAPHARMA
MANAPHARMA, officially known as MANAPHARMA Pharmaceuticals, is a leading player in the pharmaceutical industry, headquartered in Egypt (EG). Established in 2000, the company has made significant strides in the development and distribution of high-quality pharmaceutical products across the Middle East and North Africa (MENA) region. Specialising in a diverse range of therapeutic areas, MANAPHARMA is renowned for its innovative formulations and commitment to quality. The company’s core offerings include prescription medications, over-the-counter products, and specialised healthcare solutions, all designed to meet the evolving needs of patients and healthcare providers. With a strong market presence and a reputation for excellence, MANAPHARMA has achieved notable milestones, including strategic partnerships and expansions that enhance its operational capabilities. The company continues to uphold its mission of improving health outcomes through advanced pharmaceutical solutions.
DitchCarbon Score
How does MANAPHARMA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MANAPHARMA's score of 10 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
MANAPHARMA's reported carbon emissions
MANAPHARMA, headquartered in Egypt (EG), currently does not have available carbon emissions data for the most recent year. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. In the absence of concrete emissions data, it is important to note that MANAPHARMA has not outlined any specific reduction targets or initiatives related to carbon emissions. This lack of defined climate commitments may reflect a broader industry context where many companies are increasingly focusing on sustainability and climate action. As the global emphasis on reducing carbon footprints intensifies, it will be crucial for MANAPHARMA to establish clear climate commitments and reduction strategies to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MANAPHARMA is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
